Initial magnetic resonance imaging tumour regression grade (mrTRG) as response evaluation after neoadjuvant treatment predicts sustained complete response in patients with rectal cancer
Author:
Funder
China Academy of Space Technology
Cancerfonden
Karolinska Institutet
H2020 Marie Skłodowska-Curie Actions
Horizon 2020
Publisher
Elsevier BV
Subject
Oncology,General Medicine,Surgery
Reference35 articles.
1. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial;Bahadoer;Lancet Oncol,2021
2. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer;Kapiteijn;N Engl J Med,2001
3. Mesorectal excision for rectal cancer;MacFarlane;Lancet,1993
4. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data;Maas;Lancet Oncol,2010
5. Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis;Zorcolo;Ann Surg Oncol,2012
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Circulating tumour DNA and MRI circumferential resection margin are key prognostic indicators for survival in rectal cancer;ESMO Gastrointestinal Oncology;2023-12
2. A multiple-time-scale comparative study for the added value of magnetic resonance imaging-based radiomics in predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer;Frontiers in Oncology;2023-08-16
3. Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD);British Journal of Surgery;2023-03-27
4. Is It Really Gone? Assessing Response to Neoadjuvant Therapy in Rectal Cancer;Journal of Gastrointestinal Cancer;2022-11-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3